Bionovo, Inc. (Nasdaq: BNVI) today announced that the Phase 3 pivotal clinical trial evaluating the safety and efficacy of two doses of its Menerba (MF101) among a cohort of postmenopausal women for the treatment of menopausal hot flashes has been started. The Phase 3 Menerba study is currently open for enrollment of 1,200 postmenopausal women between […]